US judge declines to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk
A US judge said Eli Lilly's advertisements had only a negligible effect on Novo Nordisk. Prescriptions for Novo Nordisk's products held steady.
BTC+0.37%
ETH+0.31%
SOL-0.40%
USDC+0.02%
XRP+0.90%
SUI+0.41%
GRAMTON-2.74%
DOGE+1.60%BTC+0.37%ETH+0.31%SOL-0.40%USDC+0.02%XRP+0.90%SUI+0.41%GRAMTON-2.74%DOGE+1.60%BTC+0.37%ETH+0.31%SOL-0.40%USDC+0.02%XRP+0.90%SUI+0.41%GRAMTON-2.74%DOGE+1.60%BTC+0.37%ETH+0.31%SOL-0.40%USDC+0.02%XRP+0.90%SUI+0.41%GRAMTON-2.74%DOGE+1.60%
